Extraction and RP-HPLC determination of taxol in rat plasma, cell culture and quality control samples

Journal of Biomedical Research

Volumn 27, Issue 5, 2013, Pages 394-405

  Tekade, Rakesh Kumar ^a,b,c   D'Emanuele, Antony ^a   Elhissi, Abdelbary ^a   Agrawal, Ashish ^d   Jain, Anurekha ^d   Arafat, Basel Tawfiq ^a   Jain, Narendra Kumar ^c  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF HAWAII AT HILO   (United States)

^c DR H S GOUR UNIVERSITY   (India)

^d B R NAHATA COLLEGE OF PHARMACY   (India)

Author keywords

Extraction optimization; High performance liquid chromatography (HPLC); Micro sample rat plasma; Paclitaxel; Plasma profile

Indexed keywords

EID: 84908667971     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.27.20120123     Document Type: Article

References (42)

1. Wang F, Chen Y, Zhang D, Zhang Q, Zheng D, Hao L, et al. Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles. Int J Nanomed 2012; 7: 325-37.
2. Donehower RC, Rowinsky EK. An overview of experience with TAXOL (paclitaxel) in the U.S.A. Can Treat Rev 1993; 19: 63-78.
3. Yared JA, Tkaczuk KH. Update on taxane development: new analogs and new formulations. Drug Des Devel Ther 2012; 6: 371-84.
4. Kohler DR, Goldspiel BR. Paclitaxel (taxol). Pharmacother 1994; 14: 3-34.
5. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. J Can 1993; 68: 1104-9.
6. Hempel G, Lehmkuhl, D, Krumpelmann S, Blaschke, G, Boos J. Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography. J Chromatogr A 1996; 745: 173-9.
7. Parise RA, Ramanathan RK, Zamboni WC, Egorin MJ. Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma. J Chromatogr B 2003; 5: 231-6.
8. Leu JG, Chen BX, SchiffPB, Erlanger BF. Characterization of polyclonal and monoclonal anti-taxol antibodies and measurement of taxol in serum. Can Res 1993; 53: 1388-1391.
9. Wang LZ, Ho PC, Lee HS, Vaddi HK, Chan YW, Yung CS. Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay. J Pharm Biomed Anal 2003; 31: 283-9.
10. Coudore F, Authier N, Guillaume D, Beal A, Duroux E, Fialip JJ. High-performance liquid chromatographic determination of paclitaxel in rat serum: application to a toxicokinetic study. J Chromatogr B 1999; 721: 317-20.
11. Watchueng J, Kamnaing P, Gao JM, Kiyota T, Yeboah F, Konishi Y. Efficient purification of paclitaxel from yews using high-performance displacement chromatography technique. J Chromatogr A 2011; 20: 2929-35.
12. Hynning PA, Anderson P, Bondesson U, Boreus LO. Liquid chromatographic quantitation compared with gas chromatographic mass spectrophotometric determination of verapamil and nor verapamil in plasma. Clin Chem 1998; 34: 2502-3.
13. Gaspar JR, Qu J, Straubinger NL, Straubinger RM. Highly selective and sensitive assay for paclitaxel accumulation by tumor cells based on selective solid phase extraction and micro-flow liquid chromatography coupled to mass spectrometry. Analyst 2008; 133: 1742-8.
14. Grem JL, Tutsch KD, Simon KJ, Alberti D, Willson JK, Tormey DC, et al. Phase I study of taxol administered as a short i.v. infusion daily for 5 days. Can Treat Rep 1987; 71: 1179-84.
15. Hendrikx JJ, Hillebrand MJ, Thijssen B, Rosing H, Schinkel AH, Schellens JH, et al. A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B 2011; 15: 2984-90.
16. Shorrocks J, Paul ND, McMillan TJ. The dose rate of UVA treatment influences the cellular response of HaCaT keratinocytes. J Invest Dermatol 2008; 128: 685-93.
17. http://www.fda.gov/cder/guidance/index.htm
18. Leveque D, Jehl F. P-glycoprotein and pharmacokinetics. Antican Res 1995; 15: 331-336.
19. Benet LZ, Wu CY, Hebert MF, Wacher VJ. Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug delivery. J Cont Rel 1996; 39: 139-43.
20. Sikic, BI, Fisher GA, Joanne Halsey BL, Beketic-Oreskovic L, Chen G. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Can Chem Pharmacol 1997; 40(S): 13-9.
21. Fenaux P, Chevret S, Botton S. Treatment of older adults with acute promyelocytic leukaemia. Best Pract Res Cli Haem 2003; 16: 495-501.
22. Cassinat B, Chevret S, Zassadowski F. In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. Blood 2001; 98: 2862-4.
23. Yang T, Cui FD, Choi MK, Cho JW, Chung SJ, Shim CK, et al. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm 2007; 338: 317-26.
24. Mittal A, Chitkara D, Kumar N. HPLC method for the determination of carboplatin and paclitaxel with. cremophorEL in an amphiphilic polymer matrix. J Chromatogr B 2007; 855: 211-9.
25. Martin N, Catalin J, Blachon MF, Durand A. Assay of paclitaxel (Taxol) in plasma and urine by high-performance liquid chromatography. J Chromatogr B 1998; 709: 281-8.
26. Choi JS, Jo BW, Kim YC. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin. Eur J Pharm Biopharm 2004; 57: 313-8.
27. Woo JS, Lee CH, Shim CK, Hwang SJ. Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031. Pharm Res 2003; 20: 24-30.
28. Cresteil T, Monsarrat B, Alvinerie P, Treluyer JM, Vieira I, Wright M. Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Can Res 1994; 54: 386-92.
29. Sparreboom A, Van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DK, et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA, 1997; 94: 2031-5.
30. Candussio L, Decorti G, Crivellato E, Granzotto M, Rosati A, Giraldi T, et al. Toxicologic and pharmacokinetic study of low doses of verapamil combined with doxoru bicin. Life Sci 2002; 71: 3109-19.
31. Bartlett NL, Lum BL, Fisher GA, Brophy NA, Ehsan MN, Halsey J, et al. Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. J Clin Oncol 1994; 12: 835-42.
32. Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, et al. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol 1992; 10: 1635-42.
33. Tekade RK, Dutta T, Tyagi A, Bharti AC, Das BC, Jain NK. Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy. J Drug Target 2008; 16: 758-72.
34. Tekade RK, Vijayarajkumar P, Jain NK. Dendrimers in oncology: An expanding horizon. Chemical Reviews 2009; 109: 49-87.
35. Dhakad RS, Tekade RK, Jain NK. Cancer Targeting Potential of Folate Targeted Nanocarrier under Comparative Influence of Tretinoin and Dexamethasone. Current Drug Delivery 2012; 10:
36. Tekade RK, Dutta T, Gajbhiye V, Jain NK. Exploring Dendrimers towards Dual-Drug Delivery: pH Responsive Simultaneous Kinetics. J Microencapsulation 2009; 26: 287-96.
37. Dwivedi P, Tekade RK, Jain NK. Nanoparticulate Carrier Mediated Intranasal Delivery of Insulin for the Restoration of Memory Signaling in Alzheimer's Disease, Current Nanoscience 2013; 9: 46-55.
38. Thakur S, Tekade RK, Kesharwaniet P, Jain NK. The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers, J Nanoparticle Research 2013; 15: 1625.
39. Maheshwari RGS, Tekade RK, Sharma PA, Darwhekar G, Tyagy A, Patel RP, et al. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment, Saudi Pharmaceutical J 2012; 20: 161-70.
40. Kesharwani P, Tekade RK, Gajbhiye V, Jain NK. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison, Nanomedicine 2011; 7: 295-304.
41. Tekade RK, Dutta T, Gajbhiye V, Jain N, Jain NK. Simultaneous Spectrophotometric Estimation of Methotrexate and All trans Retinoic acid in Mixture. Asian J Chemistry 2009; 21: 5145-50.
42. Prajapati RN, Tekade RK, Gupta U, Gajbhiye V, Jain NK. Dendimer-Mediated Solubilization, Formulation Development and in Vitro-in Vivo Assessment of Piroxicam. Molecular Pharmaceutics 2009; 6: 940-50.